Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
234,732,281
-
Share change
-
-791,794
-
Total reported value
-
$95,518,842,840
-
Put/Call ratio
-
103%
-
Price per share
-
$406.89
-
Number of holders
-
1,430
-
Value change
-
-$282,404,031
-
Number of buys
-
697
-
Number of sells
-
538
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q4 2023
As of 31 Dec 2023,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,430 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
234,732,281 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, FMR LLC, STATE STREET CORP, ALLIANCEBERNSTEIN L.P., PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
1,430
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.